New Psilocybin Microdosing Data: How Much is Too Much?
Real-time gathering of physiological data and subjective effects give clues that may help define a microdose of psilocybin.
Articles
Female Hormones, 5-HT2A Receptors, and Psychedelics
Female hormones affect binding at the 5-HT2A receptor. Does this mean there is a uniquely female entourage effect with psychedelics?
The Serotonin Receptors: Comparing the Binding Affinity of 5 Psychedelics
Looking at the data side by side reveals there is much work to do, and why understanding the entourage effect is essential.
“Magic Mushroom” Microdosing Nasal Spray Announced
Nasal spray formulations could offer precision dosing of a spectrum of psychedelic mushroom compounds to consumers
Usona Follows COMPASS in Receiving Breakthrough Therapy Designation for Psilocybin to Treat Depression
This means the FDA will work to expedite the development and review of psilocybin so it can get to patients with major depressive disorder as soon as possible.
The Serotonin Receptors: An Overview and Their Importance in Psychedelic Research
From constipation to cognition, serotonin receptors play many roles in addition to the psychedelic effect.
Scientists Discover New Compounds in Magic Mushrooms
Researchers isolate ß-carbolines from several species of Psilocybe.
Psychedelics as Anti-Inflammatory Agents
A look into the less discussed therapeutic aspect of psychedelics: the anti-inflammatory effect.
Is Cannabis a Psychedelic Drug?
Yes, and it may work via 5-HT2A as well as the cannabinoid receptors.
Women and Psychedelics: The Big Picture
As psychedelic research moves ahead, some have started to identify several topics of significant interest to women.